LncRNA MEG3 enhances 131I sensitivity in thyroid carcinoma via sponging miR-182.

CONCLUSIONS: MEG3 enhanced the radiosensitivity of 131I in TC cells via sponging miR-182, indicating that MEG3 may act as a potential biomarker and therapeutic target for TC patients with 131I resistance. PMID: 30021359 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30021359?dopt=Abstract

Source: Biomed Res - July 20, 2018 Category: Research Authors: Liu Y, Yue P, Zhou T, Zhang F, Wang H, Chen X Tags: Biomed Pharmacother Source Type: research